INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 20, 2007 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 11,000 | $8.77 | 49,778 |
| Apr 20, 2007 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 11,000 | -- | 16,189 |
| Sep 25, 2003 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 11,006 | $18.96 | 603,271 |
| Sep 13, 2009 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 427
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Open market or private sale of non-derivative or derivative security | 11,007 | $16.50 | 110,658 |
| Sep 13, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 427
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4/A | Open market or private sale of non-derivative or derivative security | 11,007 | $16.50 | 110,658 |
| Feb 17, 2016 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 11,018 | $396.20 | 23,349,965 |
| Dec 31, 2014 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 11,027 | $412.78 | 21,533 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 11,066 | $9.50 | 77,752 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 11,066 | $20.00 | 66,686 |
| Jan 03, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 11,066 | -- | 8,657 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.